NMRA lab report on Mihintale tablets awaited – Health Secretary

Health Authorities are awaiting lab test reports of samples of drugs that have allegedly caused complications in pediatric patients in Mihintale, Daily News learns.

On July 13, 2024, 239 people were treated by the Outpatient Unit of Mihintale Regional Hospital. Among them, 11 children between the ages of 6-11 were admitted to Anuradhapura Teaching Hospital due to complications, and by 12.00 noon of July 15, 2024, all those children had been treated and left the hospital.

Health Secretary Dr.Palitha Mahipala said that the drugs given to these children are oral tablets and those drugs are manufactured by the State Pharmaceutical Manufacturing Corporation.1,470,000 tablets of this drug category have been distributed in the Anuradhapura district and no complaints have been reported from any other hospital so far. In order to confirm whether complications were caused by the drugs, the containers with the given drugs have been sent to the quality control laboratory of the National Medicine Regulatory Authority (NMRA) for quality control, and until the results are obtained, the use of the rest of the drug in Anuradhapura district has been suspended.

He further said that there is no relationship between the above complications and the vaccines given under the National Immunization Programme.

The post NMRA lab report on Mihintale tablets awaited – Health Secretary appeared first on DailyNews.